40
Participants
Start Date
April 30, 2010
Primary Completion Date
July 31, 2010
Study Completion Date
July 31, 2010
BMS-844421
"Ready-to-use stock solution for SC and IV, Subcutaneous, 37.5 mg~SAD: Once, 1 Day~MAD: IV loading followed by 4 weekly doses, 29 Days"
0.9% sodium chloride injection solution
"Injection solution, Subcutaneous, 37.5 mg~SAD: Once, 1 Day~MAD: IV loading followed by 4 weekly doses, 29 Days"
Local Institution, Berlin
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY